Search
Returning search results with filters:
Remove filter for
Last updated: 2019
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2019
- December 201912 results available
- November 20195 results available
- October 201910 results available
- September 20198 results available
- August 20193 results available
- July 201913 results available
- June 20199 results available
- May 201912 results available
- April 201911 results available
- March 20198 results available
- February 20193 results available
- January 20196 results available
Displaying 76 - 90 of 100 items.
Unauthorized products may pose serious health risks (December 10, 2018 to April 17, 2019)
AlertPublic advisory | 2019-04-17
Intragastric Balloons and Potential Risk of Gastric and Esophageal Perforation, Pancreatitis, and Overinflation
AlertHealth professional risk communication | 2019-04-17
Health Canada approves updates to Mifegymiso prescribing information: Ultrasound no longer mandatory
AlertInformation update | 2019-04-16
Multiple unauthorized eye solutions and an acne gel sold at two stores in the Lower Mainland of BC may pose serious health risks
AlertPublic advisory | 2019-04-15
Health Canada testing identifies additional health risks involving unauthorized products sold by A1 Herbal Ayurvedic Clinic Ltd.
AlertInformation update | 2019-04-12
Multiple unauthorized health products sold at Sunrise Lee Chinese Herbs Centre in Calgary, Alberta, may pose serious health risks
AlertPublic advisory | 2019-04-05
PrBENLYSTA (belimumab) - Increased Risk of Serious Depression, Suicidal Ideation or Behaviour, or Self-Injury
AlertHealth professional risk communication | 2019-04-04
Health Canada advises Allergan of its intent to suspend its licences for Biocell breast implants as a precautionary measure
AlertInformation update | 2019-04-04
DARZALEX (daratumumab) and Hepatitis B Virus Reactivation
AlertHealth professional risk communication | 2019-03-25
Pro Doc Limitée voluntarily recalls two lots of irbesartan drugs because of nitrosamine impurity
AlertInformation update | 2019-03-14
TECENTRIQ® (atezolizumab) - Risk of Immune-Related Myositis
AlertHealth professional risk communication | 2019-03-13
Multiple Losartan-containing drugs voluntarily recalled because of potential for nitrosamine impurity
AlertInformation update | 2019-03-09
Homeopathic remedies are not a substitute for vaccines
AlertInformation update | 2019-03-06